Profile: Replicor Inc. is a biopharmaceutical company developing entry inhibitors for the treatment of Hepatitis C and prevention of HCV re-infection following liver transplantation. We also focus on the development of Hepatitis B and influenza drugs. Our REP 9AC is a broad-spectrum antiviral having potent activity against HCV, HBV, influenza and other enveloped viruses.
6 Products/Services (Click for related suppliers)
| |||||
• | Biopharmaceutical Drugs | • | Biopharmaceuticals for Hepatitis B virus infection... | • | Biopharmaceuticals for Hepatitis C virus infection... |
• | Biopharmaceuticals for Viral And Bacterial Infecti... | • | Hepatitis B Therapy | • | Hepatitis C Therapy |